Abstract
Small supernumerary marker chromosomes (sSMC) in human are present in 0.043% of newborn children. They can be defined as additional centric chromosome fragments smaller than chromosome 20. sSMC include cases with the i(18p)-, the i(12p)- (i.e. Pallister Killian-) or the inv dup(22)- (i.e. cat-eye-) syndrome. However, about 30% of the remaining sSMC are not yet correlated with clinical syndromes, mostly due to problems in comprehensive characterisation of the sSMC. Here we present an overview of the approaches for sSMC characterisation and suggest a strategy for a straightforward and comprehensive characterisation of the marker chromosomes in question.
Keywords: small supernumerary marker chromosome, esac, ring chromosome, fluorescence in situ hybridisation, classification of ssmc
Current Genomics
Title: Characterisation of Small Supernumerary Marker Chromosomes (sSMC) in Human
Volume: 5 Issue: 3
Author(s): Thomas Liehr, Kristin Mrasek, Anja Weise, Alma Kuechler, Ferdinand von Eggeling, Uwe Claussen and Heike Starke
Affiliation:
Keywords: small supernumerary marker chromosome, esac, ring chromosome, fluorescence in situ hybridisation, classification of ssmc
Abstract: Small supernumerary marker chromosomes (sSMC) in human are present in 0.043% of newborn children. They can be defined as additional centric chromosome fragments smaller than chromosome 20. sSMC include cases with the i(18p)-, the i(12p)- (i.e. Pallister Killian-) or the inv dup(22)- (i.e. cat-eye-) syndrome. However, about 30% of the remaining sSMC are not yet correlated with clinical syndromes, mostly due to problems in comprehensive characterisation of the sSMC. Here we present an overview of the approaches for sSMC characterisation and suggest a strategy for a straightforward and comprehensive characterisation of the marker chromosomes in question.
Export Options
About this article
Cite this article as:
Liehr Thomas, Mrasek Kristin, Weise Anja, Kuechler Alma, Eggeling von Ferdinand, Claussen Uwe and Starke Heike, Characterisation of Small Supernumerary Marker Chromosomes (sSMC) in Human, Current Genomics 2004; 5 (3) . https://dx.doi.org/10.2174/1389202043349354
DOI https://dx.doi.org/10.2174/1389202043349354 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advances in Genomics and Precision Medicine for Cardiovascular Diseases
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality globally, representing a significant challenge to public health systems. Recent advancements in genomics and precision medicine offer unprecedented opportunities to transform the prevention, diagnosis, and treatment of CVDs. This special issue of Current Genomics explores the latest developments in ...read more
AI-Driven Genomics and Multi-Omics Approaches for Drug Discovery and Precision Medicine
The rapid advancements in artificial intelligence (AI) have opened new avenues in genomics and multi-omics research, providing transformative insights into disease mechanisms, biomarker discovery, and therapeutic strategies. This thematic issue explores the intersection of AI with genomics, transcriptomics, proteomics, metabolomics, and epigenomics, focusing on how computational intelligence can facilitate data ...read more
Emerging Molecular Mechanisms in Rare Genetic Skeletal Disorders: Linking Genomic Mutations to Clinical Outcomes.
Rare genetic skeletal disorders encompass a diverse group of conditions that impact bone and cartilage development, often due to pathogenic mutations in critical developmental genes. This thematic issue aims to explore the intricate molecular mechanisms underlying these disorders, providing insights into how specific genomic mutations translate into clinical phenotypes. Recent ...read more
Related Journals

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ferroptosis Inducers for Prostate Cancer Therapy
Current Medicinal Chemistry Cancer and Phase II Drug-Metabolizing Enzymes
Current Drug Metabolism Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia
Anti-Cancer Agents in Medicinal Chemistry Advanced Assessment of the Endogenous Hormone Level as a Potential Biomarker of the Urogenital Tract Cancer
Combinatorial Chemistry & High Throughput Screening Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed Therapies
Current Topics in Medicinal Chemistry Synthesis and Photobiological Properties of Bromo- and Alkoxymethyl Furocoumarins
Letters in Drug Design & Discovery Molecular Aspects of FKBP51 that Enable Melanoma Dissemination
Current Molecular Pharmacology Clinical Presentation, Outcome and Risk Factors of Late-Onset Non- Infectious Pulmonary Complications After Allogeneic Stem Cell Transplantation
Current Stem Cell Research & Therapy Zinc, Metallothioneins and Longevity: Interrelationships with Niacin and Selenium
Current Pharmaceutical Design The Application of Fungal Beta-glucans for the Treatment of Colon Cancer
Anti-Cancer Agents in Medicinal Chemistry Other Potential Therapeutic Targets in Thyroid Orbitopathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia
Current Cancer Therapy Reviews Electrochemical Indicators for DNA Electroanalysis
Current Analytical Chemistry Chemometric Evaluation of the Significance of Molecular Structural Descriptors on Binding of Acridinone Derivatives to DNA
Letters in Drug Design & Discovery Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight
Current Neuropharmacology Chemistry and Biology of Fascaplysin, a Potent Marine-Derived CDK-4 Inhibitor
Mini-Reviews in Medicinal Chemistry Recent Kinase and Kinase Inhibitor X-ray Structures: Mechanisms of Inhibition and Selectivity Insights
Current Medicinal Chemistry Targeting Strategies in Therapeutic Applications of Toxoplasmosis: Recent Advances in Liposomal Vaccine Delivery Systems
Current Drug Targets Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About?
Current Genomics Anticancer α-Helical Peptides and Structure / Function Relationships Underpinning Their Interactions with Tumour Cell Membranes
Current Protein & Peptide Science